W STRATEGIES, LLC

Lobbying for MERCK & CO., INC. · Pharmaceutical Company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · $50,000.00 income · posted Apr 18, 2025

Bills named in this filing 2

HR 5376
Impacts and Outcomes for Health Career Training Act
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…

Lobbying activity 2

Medicare/Medicaid

Implementation of H.R.5376 - Inflation Reduction Act of 2022. H.R.1492: EPIC Act.

Health Issues

Education around the Vaccine Injury Compensation Program. PBM reform legislation including efforts to delink fees in Medicare Part D.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.